Adamis Pharmaceuticals | ADMP - Stock


Adamis Pharmaceuticals reported $1.24M in Stock for its fiscal quarter ending in December of 2022.



Stock Change Date
Adma Biologics USD 222.1M 15.63M Mar/2026
Cara Therapeutics USD 900K 0 Mar/2025
Cipla INR 61.6B 5.18B Sep/2025
Clal Biotechnology ILS 4.44M 0 Mar/2021
CSL USD 6.47B 327M Jun/2025
GlaxoSmithKline GBP 6.16B 233M Mar/2026
Glaxosmithkline GBP 6.12B 46M Sep/2025
Grifols EUR 3.56B 63.19M Dec/2024
Merck USD 6.48B 179M Mar/2026
Pfizer USD 10.67B 13M Mar/2026
RedHill Biopharma USD 3.17M 482K Jun/2025